NCT05267769View on ClinicalTrials.gov

Clinical Trial on Pharmacokinetics and Tolerability of AP707

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

April 3, 2022

Study Completion Date

April 3, 2022

Conditions

PharmacokineticsTolerabilitySafety

Interventions

DRUG

AP707

Preparation of Cannabis flowers (Cannabis flos)

Trial Locations (1)

83627

Phase I Unit of CannaXan GmbH, Warngau

All Listed Sponsors

lead

CannaXan GmbH

INDUSTRY